Loading...
ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC)
Lawless, C Hatton, M Faivre-Finn, Corinne Landau, D Boyd, K Fenwick, J Lester, J Mccartney, E Paul, J Shaw, A
Lawless, C
Hatton, M
Faivre-Finn, Corinne
Landau, D
Boyd, K
Fenwick, J
Lester, J
Mccartney, E
Paul, J
Shaw, A
Citations
Altmetric:
Abstract
Description
Date
2018
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Lawless C, Hatton M, Faivre-Finn C, Landau D, Boyd K, Fenwick J, et al. P2.01-43 ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC). J Thorac Oncol. 2018 Oct;13(10):S681.